Ad is loading...
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
WIESX
Price
$17.36
Change
-$0.20 (-1.14%)
Updated
Nov 15 closing price
Ad is loading...

RNWFX vs WIESX

Header iconRNWFX vs WIESX Comparison
Open Charts RNWFX vs WIESXBanner chart's image
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
Wasatch Emerging Markets Select Instl
Price$17.36
Change-$0.20 (-1.14%)
VolumeN/A
CapitalizationN/A
RNWFX vs WIESX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWFX vs. WIESX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Buy and WIESX is a StrongSell.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. WIESX (405M). RNWFX pays higher dividends than WIESX: RNWFX (1.51) vs WIESX (0.00). RNWFX was incepted earlier than WIESX: RNWFX (23 years) vs WIESX (12 years). RNWFX is a more actively managed with annual turnover of: 32.00 vs. WIESX (14.00). RNWFX has a lower initial minimum investment than WIESX: RNWFX (250) vs WIESX (100000). WIESX annual gain was more profitable for investors over the last year : 12.14 vs. RNWFX (11.54). WIESX return over 5 years is better than : 41.48 vs. RNWFX (17.17).
RNWFXWIESXRNWFX / WIESX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years12 years-
Gain YTD7.0992.479286%
Front LoadN/AN/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets60.9B405M15,037%
Annual Yield % from dividends1.510.00-
Returns for 1 year11.5412.1495%
Returns for 3 years-14.55-29.3450%
Returns for 5 years17.1741.4841%
Returns for 10 years41.0063.1665%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics